30 April 1999
Application of nonspecific bronchial challenge tests-when, how and why?
Jerzy Mosiewicz, Wojciech Myśliński, Maria Jaszyna, Janusz HanzlikMed Sci Monit 1999; 5(3): RA591-595 :: ID: 505069
Abstract
A term 'bronchial hyperreactivity' refers to abnormally strong bronchospasm caused by many various factors that in normal conditions are not able to produce such response. In practice the assessment of bronchial reactivity is based on bronchial challenge tests. The aim of our study is to present currently used bronchial provocation tests, consisted of assessment of initial pulmonary function parameters, administration of a bronchospastic challenging agent, measurement and interpretation of observed changes. Histamine and methacholine are the most commonly used provocation agents. Safety, usefulness, nonallergenic activity of these agents allows obtained results to be repeatable. Bronchial provocation tests may be used to confirm existing bronchial hyperreactivity but also to evaluate 'severity' of asthma and its response to pharmacological treatment. Positive tests correspond with diagnosis of asthma but have less diagnostic value because they can also be positive in several other diseases such as e.g. COPD, cystic fibrosis, bronchiectasis, sarcoidosis, viral respiratory tract infections, heart failure or reflux oesophagitis. Provocation tests are particularly important in cases of bronchial asthma clinically manifested by cough without wheezing and flow limitation syndrome. Properly performed bronchial provocation tests are safe. Relative contraindications may be diagnosed: history of unexplained urticaria or Quincke's edema, severe airflow obstruction, unstable angina and pregnancy. If initial results of spirometry are normal, bronchospasm will spontaneously regress within 30-45 min. or even within 5 min. after administration of bronchodilators. Symptoms including cough, chest discomfort, breathlessness, sore throat, excessive salivation, headache and dizziness are usually mild and last for several minutes.
Keywords: methacholine, Asthma, Bronchial Hyperreactivity
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952